Ronald Wharton, MD
Associate Professor of Cardiology, Zucker School of Medicine at Hofstra University Director, Hypertrophic Cardiomyopathy Program, North Shore University Hospital
Life Sciences
Discover how we work with life sciences partners to drive patient care innovation.
Hypertrophic cardiomyopathy (HCM) is the most common, inherited cardiovascular disease and one of the leading causes of sudden cardiac death in people under age 35. However, only 20% of people with this disease have been diagnosed.
Viz HCM is an artificial intelligence (AI) workflow software that detects suspected HCM on electrocardiograms (ECGs) in real time and directs patients to the appropriate care specialists for further recommended workup.
In this webinar, Dr. Ronald Wharton, HCM Program Director at NorthShore University Hospital, will discuss with Jayme Strauss, Viz.ai’s Chief Clinical Officer:
Ronald Wharton, MD
Associate Professor of Cardiology, Zucker School of Medicine at Hofstra University Director, Hypertrophic Cardiomyopathy Program, North Shore University Hospital
Jayme Strauss, RN, MSN, MBA, SCRN
Chief Clinical Officer
Schedule a meeting
Experience the power of AI
See for yourself how you can harness the power of AI to accelerate patient access to care through AI-powered care coordination.